Candriam Luxembourg S.C.A. lowered its stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 18.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 62,283 shares of the medical instruments supplier’s stock after selling 13,820 shares during the quarter. Candriam Luxembourg S.C.A.’s holdings in DENTSPLY SIRONA were worth $4,100,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently bought and sold shares of XRAY. Bessemer Group Inc. raised its stake in shares of DENTSPLY SIRONA by 4,638.6% in the third quarter. Bessemer Group Inc. now owns 1,903,596 shares of the medical instruments supplier’s stock worth $113,855,000 after buying an additional 1,863,424 shares during the period. Alyeska Investment Group L.P. raised its stake in shares of DENTSPLY SIRONA by 223.7% in the third quarter. Alyeska Investment Group L.P. now owns 2,271,534 shares of the medical instruments supplier’s stock worth $135,860,000 after buying an additional 1,569,746 shares during the period. Frontier Capital Management Co. LLC bought a new position in shares of DENTSPLY SIRONA in the fourth quarter worth about $60,449,000. Jackson Square Partners LLC raised its stake in shares of DENTSPLY SIRONA by 15.6% in the third quarter. Jackson Square Partners LLC now owns 6,334,906 shares of the medical instruments supplier’s stock worth $378,890,000 after buying an additional 855,199 shares during the period. Finally, Victory Capital Management Inc. raised its stake in shares of DENTSPLY SIRONA by 22,502.5% in the fourth quarter. Victory Capital Management Inc. now owns 855,955 shares of the medical instruments supplier’s stock worth $56,348,000 after buying an additional 852,168 shares during the period. 96.51% of the stock is currently owned by hedge funds and other institutional investors.
Shares of DENTSPLY SIRONA Inc (XRAY) opened at $58.43 on Friday. The stock has a market capitalization of $13,510.00, a P/E ratio of -16.79, a P/E/G ratio of 2.11 and a beta of 1.17. DENTSPLY SIRONA Inc has a 12 month low of $52.53 and a 12 month high of $68.98. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Thursday, March 29th will be paid a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a yield of 0.60%. The ex-dividend date is Wednesday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.06%.
In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,409 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $68.04, for a total value of $436,068.36. Following the sale, the director now owns 12,073 shares of the company’s stock, valued at approximately $821,446.92. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.99% of the stock is currently owned by company insiders.
Several analysts recently issued reports on XRAY shares. Stifel Nicolaus lifted their target price on DENTSPLY SIRONA from $66.00 to $70.00 and gave the company a “buy” rating in a research note on Monday, November 6th. BidaskClub downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a research note on Saturday, December 2nd. Barrington Research raised DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 target price on the stock in a research note on Monday, November 6th. HC Wainwright reissued a “hold” rating and set a $68.00 target price on shares of DENTSPLY SIRONA in a research note on Thursday, January 18th. Finally, Stephens started coverage on DENTSPLY SIRONA in a research note on Tuesday, November 28th. They set an “overweight” rating and a $75.00 target price on the stock. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and eight have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $69.15.
ILLEGAL ACTIVITY WARNING: This piece of content was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/17/candriam-luxembourg-s-c-a-sells-13820-shares-of-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.